Dysmetabolic syndrome as a focus in risk reduction has identified many individuals as at-risk for type 2 diabetes and/or cardiovascular disease who may have gone unrecognized and untreated until much later in the disease trajectory.
ABOUT THE AUTHORS
Dr. Appel is an Assistant Professor, Graduate Division, in the School of Nursing, University of Alabama at Birmingham. Joyce Newman Giger is a Professor and Hassenplug Endowed Chair at the School of Nursing, UCLA, Los Angeles, Calif. Natalie A. Floyd is a Doctoral Student at the University of Alabama at Birmingham, and an Adult Nurse Practitioner at the Veterans Hospital, Birmingham.
The authors have disclosed they have no significant relationship or financial interest in any commercial companies that pertain to this education activity.